Nurse Practitioners Secure No. 1 Spot Across Three U.S. News & World Report Best Jobs Rankings
A Groundbreaking Forum at HIMSS25 Focused on Behavioral Health
Artificial Intelligence (AI) in Medical Imaging Market to Hit USD 4.54 Billion by 2029 with 22.4% CAGR | MarketsandMarkets™
Purina Awards $125,000 to Five U.S.-Based Pet Startups through 2025 Pet Care Innovation Prize
Data Innovations Appoints New President and CEO, Eric Dingfelder
‘Re-purposing anti-TNF for Dupuytren’s Disease’ Being Presented Wednesday, December 1, 2021, at 3pm ESTPALO ALTO, Calif., Nov. 18, 2021 (GLOBE...
ST. LOUIS, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
BUFFALO, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
Combination based on both strong mechanistic rationale and preclinical dataSOUTH SAN FRANCISCO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics,...
BRIDGEWATER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that...
Louvain-La-Neuve, Belgium, and BELOIT, Wis., USA November 18, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in...
NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire - Brain Scientific Inc. (OTCQB: BRSF) a leader in the...
-- Veru is a Late-Stage Clinical Development Biopharmaceutical Company Developing Drugs for the Treatment of Breast Cancer, Prostate Cancer, and...
ROCKVILLE, Md., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives...
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
SAN DIEGO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...
Capital from upsized IPO plus substantial NIA grants supports clinical progress of novel small-molecule σ-2 modulators into new indicationsPURCHASE, N.Y.,...
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated...
Brings total Series A financing to $26 million Funds to support expansion of leadership team, continued R&D activities and pre-clinical...
PRAGUE, Czech Republic, Nov. 18, 2021 (GLOBE NEWSWIRE) -- SOTIO Biotech, a clinical stage immune-oncology company owned by PPF Group,...
Latest interim analysis shows Rhenium-186 NanoLiposome (186RNL) well-tolerated without dose-limiting toxicities Mean and median overall survival in patients receiving absorbed...
AUSTIN, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company...
Phase 2 clinical trial underway for Hypoplastic Left Heart Syndrome, which affects approximately 1,000 babies per yearMIAMI, Nov. 18, 2021...
Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposalsMONMOUTH JUNCTION, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE)...
